Established in 1984, the Foundation is the controlling owner of LEO Pharma and its main objective is to ensure the company's long-term development and success as a global leader in dermatology, delivering outstanding results.

Besides the ownership, the LEO Foundation provides philanthropic grants with the aim to support the best international research in skin diseases and make Denmark a global beacon for skin research.

In addition, the LEO Foundation owns financial assets of around EUR 2 billion. The main objectives of the investments are to ensure continued capability to support LEO Pharma’s long-term development and provide funds for the Foundation’s philanthropic activities.